ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) traded at $0.52 at close of the session on Friday, January 03 and made an upward move of 15.53% on its previous day’s price.
Looking at the stock we see that its previous close was $0.45 and the beta (5Y monthly) reads 0.273 with the day’s price range being $0.45 – $0.5383. In terms of its 52-week price range, IPA has a high of $2.60 and a low of $0.32. The company’s stock has gained about 44.34% over that past 30 days.
ImmunoPrecise Antibodies Ltd has a market cap of $18.66 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the IPA stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 25.53% off its SMA20 and 20.35% from its 50-day simple moving average. The RSI (14) is pointing at 70.24 while the volatility over the past week is 12.78% and jumps to 10.91% over the past one month. The beta value is 0.18, while the average true range (ATR) is currently pointing at 0.05.
Coming back to ImmunoPrecise Antibodies Ltd (NASDAQ:IPA), we note that the average 3-month trading volume was 550.44K, while that of the preceding 10-day period stands at 0.38 million. Current shares outstanding are 30.29 million.
The insiders hold 12.52% of the company’s shares while institutions hold 7.71%. The data shows that short shares as of 2024-11-15, stood at 0.69 million at a short ratio of 0.7. This represents a 241.00 short interest in shares outstanding on 2024-11-15. Shares short rose in November from the previous month at 0.15 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 26.28% up in year-to-date price movement.
